LifeArc



Pheno Therapeutics launches with £5m investment

Pheno Therapeutics, a new drug-discovery spin-out from the University of Edinburgh, has been launched with the backing of Series A funding totalling £5 million from Advent Life Sciences, the Scottish Investment Bank and LifeArc.

Published 18 February 2020